| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |